Methandrostenolone (Dianabol) 50mg

Methandrostenolone 50mg (Dianabol) | NexorinPharma

Methandrostenolone 50mg is an oral anabolic steroid containing 50mg of Methandrostenolone per tablet. At NexorinPharma, we carry Methandrostenolone 50mg as part of our oral anabolic steroid inventory for customers in markets where Methandrostenolone is legally available.

Methandrostenolone is the active compound in this preparation, widely known under the brand name Dianabol. It is one of the most historically significant oral anabolic steroids ever developed and carries a well-documented presence in both clinical research and performance community discussions spanning several decades.

The 50mg per tablet concentration represents the highest commonly available non-prescription Methandrostenolone tablet format. This significantly exceeds both historical pharmaceutical clinical tablet formats and the standard 10mg and 20mg non-prescription formats. This distinction carries important health and legal considerations that anyone researching this specific product should understand clearly. This page covers what Methandrostenolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice, recommend steroid use, or provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

About the 50mg Concentration

The 50mg per tablet concentration represents the highest commonly available non-prescription Methandrostenolone tablet format. Understanding this context is essential for anyone researching this specific product and comparing it to other available formats.

Comparison With Historical Clinical Formats

Historical pharmaceutical grade Dianabol tablets were available at 2.5mg and 5mg formats in US clinical settings before market withdrawal. The 50mg concentration consequently exceeds historical US pharmaceutical clinical tablet formats by a factor of 10 to 20 times. This distinction is directly relevant to understanding the health risk profile of the 50mg format compared to the clinical research base established at historical doses.

Comparison With Lower Non-Prescription Formats

Non-prescription Methandrostenolone is available at 10mg and 20mg tablet formats in performance markets. The 50mg format delivers five times the active compound per tablet compared to the standard 10mg format and two and a half times the active compound compared to the 20mg format. As a result, the dose-dependent side effect considerations associated with Methandrostenolone are significantly more pronounced per tablet at the 50mg concentration than at lower formats.

Non-Prescription Market Context

Methandrostenolone 50mg is produced for markets where Methandrostenolone is legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade prescription products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.

What Is Methandrostenolone

Methandrostenolone is a synthetic anabolic-androgenic steroid derived from testosterone. CIBA developed it in the late 1950s and introduced it to the US market under the brand name Dianabol in 1958. It was consequently one of the first anabolic steroids specifically developed for performance enhancement alongside its clinical applications and became one of the most widely used and discussed oral anabolic steroids in history.

Structurally, Methandrostenolone is a modified form of testosterone. A methyl group at the 17-alpha position allows it to survive first-pass liver metabolism when taken orally. In addition, a double bond between carbon atoms 1 and 2 of the steroid structure reduces its androgenic activity relative to testosterone while preserving strong anabolic activity. These structural modifications produce an oral anabolic steroid with significant anabolic potency and meaningful estrogenic activity through aromatization.

The resulting pharmacological profile produces an anabolic rating of 90 to 210 and an androgenic rating of 40 to 60 relative to a testosterone baseline of 100. Strong anabolic activity combined with significant estrogenic conversion and notable liver toxicity consequently defines Methandrostenolone’s pharmacological profile across all concentration formats.

How Methandrostenolone Works

Methandrostenolone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.

Androgen Receptor Binding

Methandrostenolone binds to androgen receptors throughout the body. Its androgenic rating of 40 to 60 is lower than testosterone’s baseline of 100, reflecting its reduced androgenic activity relative to its anabolic potency. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively lower androgenic activity in androgen-sensitive tissues than testosterone-based compounds.

Nitrogen Retention

Methandrostenolone produces very strong positive nitrogen retention in muscle tissue. The body retains significantly more nitrogen than it excretes. Consequently, this produces a pronounced anabolic environment that strongly favors rapid muscle repair and growth. At the 50mg concentration, this nitrogen retention effect is more pronounced per tablet than at lower formats.

Protein Synthesis

Methandrostenolone accelerates protein synthesis in skeletal muscle tissue at a rate consistent with its high anabolic rating. Faster protein synthesis supports rapid muscle repair and growth following training. This mechanism is directly tied to its androgen receptor activity and is more pronounced at the 50mg concentration compared to lower formats.

Aromatization to Estrogen

Methandrostenolone converts to estrogen through the aromatase enzyme pathway. This aromatization produces significant estrogen elevation and drives estrogenic side effects including water retention, gynecomastia, and mood changes. As a result, estrogen management is a primary consideration with Methandrostenolone use. At the 50mg concentration, estrogenic side effect management is consequently significantly more relevant than at lower formats.

Glycogenolysis

Methandrostenolone enhances glycogenolysis, improving muscular energy availability during training. This mechanism is one of the consistently documented pharmacological characteristics of Methandrostenolone and contributes to the strength and performance observations discussed in performance communities. Furthermore, this glycogenolytic effect distinguishes Methandrostenolone from anabolic steroids that do not produce meaningful glycogenolytic activity.

IGF-1 Stimulation

Methandrostenolone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism consequently contributes to the recovery-related observations consistently reported in performance community discussions about Methandrostenolone use.

Clinical Background

Methandrostenolone carries a documented clinical history that provides relevant context for its pharmacological profile.

Original Clinical Development

CIBA developed Methandrostenolone in the late 1950s with specific clinical applications including treatment of hypogonadism, osteoporosis, and muscle wasting conditions. It was FDA approved and commercially available in the United States under the Dianabol brand name from 1958. The FDA subsequently withdrew its approval in 1985 after CIBA discontinued marketing the drug. It continued production in other countries following US market withdrawal.

Muscle Wasting and Osteoporosis

Methandrostenolone was used clinically for the treatment of muscle wasting conditions and osteoporosis. Its potent anabolic effects on muscle tissue and bone provided clinical relevance for these indications. This clinical history consequently provides a broader research base for understanding its pharmacological profile and documented anabolic effects in human subjects.

Clinical Dose Context

The clinical research base for Methandrostenolone was established at doses significantly lower than the 50mg per tablet format. The safety and efficacy data accumulated in clinical settings does not directly reflect the pharmacological and health risk profile of the 50mg concentration format. Anyone evaluating the 50mg format should understand this distinction from the available clinical literature.

Methandrostenolone 50mg Versus Other Formats and Oral Anabolic Steroids

Versus Methandrostenolone 10mg and 20mg

Both lower concentration preparations contain the same active compound with identical pharmacological profiles. The 50mg format delivers five times the active compound per tablet compared to the 10mg format and two and a half times compared to the 20mg format. As a result, dose-dependent side effect considerations including liver toxicity, estrogenic effects, and cardiovascular impact are significantly more pronounced per tablet at the 50mg concentration.

Versus Oxymetholone (Anadrol) 50mg

Oxymetholone 50mg is another high-concentration oral anabolic steroid with significant liver toxicity. Both compounds are 17-alpha alkylated with significant hepatotoxicity profiles. Oxymetholone produces estrogenic effects through direct estrogen receptor activation rather than conventional aromatization, while Methandrostenolone aromatizes directly to estrogen. Both carry similar per-tablet concentration formats at 50mg. Oxymetholone consequently represents a comparably aggressive compound to the 50mg Methandrostenolone format in terms of overall pharmacological potency and side effect profile.

Versus Oxandrolone (Anavar)

Oxandrolone is a non-aromatizing oral anabolic steroid with significantly milder liver toxicity than Methandrostenolone at any concentration. Compared to the 50mg Methandrostenolone format, Oxandrolone produces no estrogenic conversion, dramatically lower liver stress, and a significantly more favorable overall side effect profile. These two compounds consequently occupy opposite ends of the oral anabolic steroid potency and risk spectrum.

Versus Stanozolol (Winstrol)

Stanozolol is a non-aromatizing oral anabolic steroid with significant liver toxicity. Unlike Methandrostenolone at any concentration, Stanozolol does not produce estrogenic effects through aromatization. Both carry 17-alpha alkylation-related liver toxicity. However, Methandrostenolone’s significant aromatization at the 50mg concentration produces a fundamentally more pronounced estrogenic side effect profile than Stanozolol.

Side Effects and Health Risks

Methandrostenolone 50mg carries a well-documented side effect profile. The 50mg concentration per tablet makes all dose-dependent side effect considerations significantly more pronounced than at lower formats. These risks are serious and cannot be minimized in any responsible discussion of this compound at this concentration.

Liver Toxicity

Liver toxicity is the most serious health concern associated with Methandrostenolone use. As a 17-alpha alkylated oral steroid, the alkylation places significant and direct stress on liver tissue. At the 50mg concentration, liver stress considerations are significantly more pronounced than at the 10mg and 20mg formats. Clinical research and case reports document elevated liver enzymes and in cases of prolonged or high-dose use, serious hepatic complications. Liver monitoring through regular blood work is therefore absolutely essential for anyone using this compound at any concentration.

Estrogenic Effects

Methandrostenolone converts significantly to estrogen through the aromatase enzyme pathway. At the 50mg concentration, estrogenic side effect management is significantly more relevant than at lower formats. Elevated estrogen levels consequently produce pronounced water retention, gynecomastia, and mood changes. Aromatase inhibitors are commonly referenced in performance communities for managing estrogen conversion with Methandrostenolone use and are particularly relevant at the 50mg concentration.

Cardiovascular Effects

Methandrostenolone produces significant adverse lipid profile changes. HDL cholesterol drops sharply while LDL cholesterol increases substantially. Furthermore, water retention from estrogenic activity contributes to elevated blood pressure. At the 50mg concentration, these cardiovascular considerations are significantly more pronounced than at lower formats. Regular cardiovascular monitoring is therefore essential for anyone using this compound.

Hormonal Suppression

Methandrostenolone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. Post-use hormonal disruption can persist for months. In some cases, it results in long-term or permanent hypogonadism requiring ongoing medical treatment. At the 50mg concentration, the degree of HPG axis suppression is consequently more pronounced than at lower formats.

Androgenic Effects

Despite its relatively low androgenic rating, Methandrostenolone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne. In women, virilization risks are serious considerations. At the 50mg concentration, these androgenic considerations are consequently more pronounced than at lower formats.

Blood Pressure

Water retention from estrogenic activity and adverse lipid changes both contribute to blood pressure increases. At the 50mg concentration, blood pressure monitoring is consequently significantly more relevant than at lower formats.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Methandrostenolone use at any concentration and are consequently most pronounced at the 50mg format compared to all lower concentration alternatives.

Legal and Regulatory Status

Methandrostenolone carries Schedule III controlled substance status in the United States under the Controlled Substances Act. The FDA withdrew its approval in 1985 after CIBA discontinued marketing. Possession without a valid prescription is consequently a federal offense.

In the United Kingdom, Methandrostenolone falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Methandrostenolone alongside all major athletic governing bodies. As a result, it appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Methandrostenolone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Methandrostenolone 50mg Available at NexorinPharma

Yes. NexorinPharma carries Methandrostenolone 50mg for customers in markets where Methandrostenolone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Methandrostenolone

Methandrostenolone produces a half-life of approximately 3 to 6 hours. As a result, its relatively short half-life requires regular daily administration to maintain stable plasma concentrations throughout the day.

How Does the 50mg Concentration Differ From the 10mg and 20mg Formats

All three preparations contain the same active Methandrostenolone compound with identical pharmacological profiles. The 50mg format delivers five times the active compound per tablet compared to the 10mg format and two and a half times compared to the 20mg format. As a result, all dose-dependent side effect considerations are significantly more pronounced per tablet at the 50mg concentration.

Does Methandrostenolone Aromatize

Yes. Methandrostenolone converts significantly to estrogen through the aromatase enzyme pathway. Consequently, estrogenic side effects including water retention and gynecomastia are primary health considerations with this compound, particularly at the higher 50mg concentration.

What Are the Most Serious Health Risks

Liver toxicity from 17-alpha alkylation is the most serious health concern. In addition, cardiovascular effects from significant lipid dysregulation and water retention, estrogenic effects, and hormonal suppression complete the primary risk profile. These considerations are significantly more pronounced at the 50mg concentration than at any lower format. Medical supervision and regular blood work monitoring are therefore absolutely essential for anyone using this compound.

Is Methandrostenolone 50mg Legal to Purchase

Methandrostenolone carries Schedule III controlled substance status in the United States. Legal status varies by jurisdiction. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Methandrostenolone 50mg

Methandrostenolone has one of the most extensively documented pharmacological profiles of any oral anabolic steroid. Decades of clinical research, observational data, and performance community discussion provide a substantial body of information about its effects and risk profile. That research base applies to its pharmacological profile regardless of the specific concentration format. However, the clinical research base was established at doses significantly lower than the 50mg per tablet format, meaning it does not fully reflect the health risk profile at this concentration.

The 50mg concentration delivers five times the active compound per tablet compared to the standard 10mg format. As a result, all dose-dependent side effect considerations are significantly more pronounced at the 50mg concentration than the available clinical research at lower historical doses reflects. Non-prescription preparations furthermore do not carry the manufacturing oversight of pharmaceutical grade products.

Methandrostenolone carries documented liver, cardiovascular, estrogenic, hormonal, androgenic, and psychological health risks. At the 50mg concentration, these risks are significantly more pronounced than at lower formats. Medical supervision and regular blood work monitoring including liver enzymes, lipid panels, estrogen levels, and hormone levels is therefore absolutely essential for anyone using this compound.

For customers in markets where Methandrostenolone is legally available, visit nexorinpharma.com to check current Methandrostenolone 50mg availability, pricing, and stock levels.